Profile
AKLI GEHC VEEV GEHCV DOCS HQY
Company Name Akili, Inc. GE HealthCare Technologies Inc. Veeva Systems Inc. GE HealthCare Technologies Inc. Doximity, Inc. HealthEquity, Inc.
Sector Healthcare Healthcare Healthcare Healthcare Healthcare Healthcare
Industry Medical - Healthcare Information Services Medical - Healthcare Information Services Medical - Healthcare Information Services Medical - Healthcare Information Services Medical - Healthcare Information Services Medical - Healthcare Information Services
Market Cap $34.10M $38.56B $34.23B $25.46B $9.48B $8.98B
Employees 0.07K 51.00K 7.17K 51.00K 0.83K 3.13K
CEO Mr. Matthew Franklin M.B.A. Mr. Peter J. Arduini Mr. Peter P. Gassner Mr. Peter J. Arduini Mr. Jeffrey A. Tangney Mr. Jon Kessler
Ratings
AKLI GEHC VEEV GEHCV DOCS HQY
Quant Rating Score 3 3 3 3 3
Quant Rating Neutral Neutral Neutral Neutral Neutral
Trading
AKLI GEHC VEEV GEHCV DOCS HQY
Last Close $0.4331 $84.13 $210.86 $56 $50.77 $103.61
High 52 $0.47 $93.87 $250.45 $56 $61.25 $104.65
Low 52 $0.21 $71.55 $171.41 $56 $22.99 $67.98
Price vs. 52 Week High -7.85 % -10.38 % -15.81 % 0 % -17.11 % -0.99 %
Price vs. 52 Week Low 106.24 % 17.58 % 23.01 % 0 % 120.84 % 52.41 %
Total Return
AKLI GEHC VEEV GEHCV DOCS HQY
1 Month Return 0 % 3.74 % -7.83 % 0 % -2.63 % 8.36 %
3 Month Return 0 % -7.25 % 0.41 % 0 % 15.75 % 23.6 %
6 Month Return 0 % 4.91 % 13.52 % 0 % 78.39 % 34.45 %
9 Month Return 88.96 % -2.32 % 4.58 % 0 % 99.72 % 29.14 %
YTD Return 0 % 7.61 % 0.29 % 0 % -4.91 % 7.98 %
1 Year Return 9.37 % 10.45 % 1.04 % 0 % 71.87 % 43.13 %
3 Year Return 0 % 0 % 0 % 0 % 0 % 0 %
5 Year Return 0 % 0 % 0 % 0 % 0 % 0 %
Dividends
AKLI GEHC VEEV GEHCV DOCS HQY
Dividend Yield Percentage (TTM) - 0.18 % - 0.18 % - -
Dividend Paid and Capex Coverage Ration (TTM) -131.8 % 4.67 % 55.98 % 4.67 % 76.15 % 0.68 %
Dividend Per Share (TTM) - 0.16 % - 0.16 % - -
Payout Ratio (TTM) - 3.22 % - 3.22 % - -
Growth
AKLI GEHC VEEV GEHCV DOCS HQY
Asset Growth -44.39 % 17.85 % 23.03 % 17.85 % -5.06 % 2.42 %
Gross Profit Growth 827.97 % 10.35 % 9.1 % 10.35 % 16.19 % 27.05 %
Revenue Growth 419.5 % 6.6 % 9.68 % 6.6 % 13.45 % 16 %
Revenue 3 Year -57.58 % 13.84 % 51.42 % 13.84 % 119.55 % 18.22 %
Revenue 5 Year -91.64 % 17.47 % 166.6 % 17.47 % 400.08 % 151.49 %
Revenue 10 Year -91.64 % 17.47 % 624.81 % 17.47 % 400.08 % 6.45 %
EBIT Growth 28.88 % -3.45 % -6.48 % -3.45 % 30.99 % 229.19 %
Net Income Growth -647.02 % -18.16 % 7.79 % -18.16 % 30.81 % 313.1 %
Net Income 3 Yeari Growth Per Share -130.97 % -23.86 % 29.84 % -23.86 % 180.84 % 447.15 %
Net Income 5 Yeari Growth Per Share -187.08 % 2.82 % 122.44 % 2.82 % 1598.33 % -45.52 %
Net Income 10 Yeari Growth Per Share -187.08 % 2.82 % 1334.57 % 2.82 % 1598.33 % 198.41 %
Operating Income Growth 28.88 % -3.45 % -6.48 % -3.45 % 30.99 % 229.19 %
Operating Cash Flow Growth (CFG) 30.72 % -0.57 % 16.77 % -0.57 % 2.5 % 61.19 %
Operating 3 Year CFG -134.68 % 24.46 % 55.16 % 24.46 % 111.99 % 16 %
Operating 5 Year CFG -96.1 % 5.56 % 185.13 % 5.56 % 984.18 % 54.72 %
Operating 10 Year CFG -96.1 % 5.56 % 1306.57 % 5.56 % 984.18 % -10.98 %
EPS Growth -181.48 % -27.96 % 4.14 % -27.96 % 34.48 % 309.68 %
EPS Diluted Growth -181.48 % -28.44 % 7.33 % -28.44 % 35.85 % 306.45 %
Book Value Per Share -79.79 % -22.1 % 20.98 % -22.1 % -5.23 % 5.94 %
Share Holder 3 Year Equity Growth Per Share 155.56 % -51.6 % 92.35 % -51.6 % 1190.4 % 28.06 %
Share Holder 5 Year Equity Growth Per Share 170.86 % - 264.94 % - 1575.37 % 208.27 %
Share Holder 10 Year Equity Growth Per Share 170.86 % - 968.64 % - 1575.37 % 295.2 %
Dividend Per Share Growth - - - - - -
Dividend 3 Year Growth Per Share - - - - - -
Dividend 5 Year Growth Per Share - - - - - -
Dividend 10 Year Growth Per Share - - - - - -100 %
Debt Growth -22.43 % 19.57 % -8.53 % 19.57 % -6.98 % -6.17 %
Free Cash Flow Growth 30.58 % -4.94 % 13.77 % -4.94 % 2.81 % 524.15 %
Updated On 31 Dec 2023 31 Dec 2023 31 Jan 2024 31 Dec 2023 31 Mar 2024 31 Jan 2024
Profitability
AKLI GEHC VEEV GEHCV DOCS HQY
Gross Profit Margin TTM 56.11 % 41.3 % 73.79 % 41.3 % 89.94 % 58.4 %
Return on Assets TTM -72.06 % 4.95 % 10.32 % 4.95 % 15.57 % 2.77 %
Return on Equity TTM -74.46 % 21.87 % 13.17 % 21.87 % 19.13 % 4.6 %
Return on Capital Employed TTM -100.14 % 10.2 % 11.41 % 10.2 % 20.26 % 4.96 %
Net Income Per EBT TTM 100 % 71.11 % 77.71 % 71.11 % 76.93 % 83.51 %
EBT Per Ebit TTM 86.33 % 91.75 % 134.26 % 91.75 % 113.28 % 70.06 %
EBIT Per Revenue TTM -2886.6 % 13.14 % 24.03 % 13.14 % 38.66 % 14.37 %
Cash Flow To Debt Ratio TTM -358.75 % 19.45 % 1503.85 % 19.45 % 1669.74 % 630.07 %
Receivables Turnover TTM 13.53 4.65 8.82 4.65 4.14 10.78
Payables Turnover TTM 0.78 3.94 21.86 3.94 18.77 46.23
Inventory Turnover TTM - 5.41 - 5.41 - -
Fixed Asset Turnover TTM 85.55 % 770.3 % 2289.56 % 770.3 % 2287.75 % 2360.41 %
Asset Turnover TTM 2.89 % 57.77 % 41.17 % 57.77 % 46.21 % 32.98 %
Operating Cash Flow Per Share TTM -0.62 4.57 6.66 4.57 1.21 3.91
Free Cash Flow Per Share TTM -0.63 3.71 6.54 3.71 1.19 -1.86
Cash Per Share TTM 80.66 % 776.81 % 3125.55 % 776.81 % 432.51 % 369.48 %
Operating Cash Flow Sales Ratio TTM -2503.34 % 10.68 % 40.59 % 10.68 % 43.58 % 29.66 %
Free Cash Flow Operating Cash Flow Ratio TTM 100.76 % 81.18 % 98.21 % 81.18 % 98.69 % -47.48 %
Cash Flow Coverage Ratios TTM -358.75 % 19.45 % 1503.85 % 19.45 % 1669.74 % 630.07 %
Price To Free Cash Flows Ratio TTM -0.69 22.75 32.33 22.75 42.64 -55.43
Price To Operating Cash Flows Ratio TTM -0.7 18.47 31.68 18.47 41.98 26.48
Price Cash Flow Ratio TTM -0.7 18.47 31.68 18.47 41.98 26.48
Income Statement (TTM)
AKLI GEHC VEEV GEHCV DOCS HQY
Revenue $0B $19.55B $2.36B $19.55B $0.48B $1B
Gross Profit $0B $7.92B $1.69B $7.92B $0.42B $0.62B
Gross Profit Ratio 51.19% 40.52% 71.35% 40.52% 89.34% 62.29%
EBITDA $-0.06B $3.51B $0.46B $3.51B $0.18B $0.28B
Net Income $-0.06B $1.57B $0.53B $1.57B $0.15B $0.06B
EPS Diluted -0.76 3.02 3.22 3.02 0.72 0.64
Balance Sheet (MRQ)
AKLI GEHC VEEV GEHCV DOCS HQY
Long Term Debt $0.01B $8.75B $0.05B $8.75B $0.01B $0.92B
Total Liabilities $0.02B $25.14B $1.27B $25.14B $0.18B $1.13B
Total Equity $0.06B $7.31B $4.64B $7.31B $0.9B $2.04B
Total Investments $0B $0.36B $3.32B $0.36B $0.67B $0.84B
Total Debt $0.02B $9.86B $0.06B $9.86B $0.01B $0.93B
Total Assets $0.08B $32.45B $5.91B $32.45B $1.08B $3.16B
Cash Flow Statement (TTM)
AKLI GEHC VEEV GEHCV DOCS HQY
Net Income $-0.06B $1.57B $0.53B $1.57B $0.15B $0.06B
Inventory $-0B $0.11B $0B $0.11B $0B $0B
Dividends Paid $0B $-0.04B $0B $-0.04B $0B $0B
Operating Cash Flow $-0.06B $2.1B $0.91B $2.1B $0.18B $0.24B
Capital Expenditure $-0B $-0.39B $-0.03B $-0.39B $-0.01B $-0.05B
Related Stocks
Ticker Name Price
ACCD Accolade, Inc. 6.865
ACON Aclarion, Inc. 0.039
ACONW Aclarion, Inc. 0.0359
AGTI Agiliti, Inc. 10.05
AMWL American Well Corporation 8.3
AUGX Augmedix, Inc. 2.345
BBLN Babylon Holdings Limited 0.5504
BEAT HeartBeam, Inc. 2.12
BEATW HeartBeam, Inc. 0.4502
BFRG Bullfrog AI Holdings, Inc. Common Stock 2.1439
BFRGW Bullfrog AI Holdings, Inc. Warrants 0.5447
BTSG BrightSpring Health Services, Inc. Common Stock 18.05
BTSGU BrightSpring Health Services, Inc. Tangible Equity Unit 65.82
CCLD CareCloud, Inc. 2.845
CCLDO CareCloud, Inc. 18.652
CCLDP CareCloud, Inc. 19.17
CERN Cerner Corporation 94.92
CERT Certara, Inc. 11.75
CHNG Change Healthcare Inc. 27.49
CHNGU Change Healthcare Inc. 73.71
ETFs With Exposure to AKLI
Ticker ETF Name Weight Percentage Price
VTI Vanguard Total Stock Market Index Fund 0 293.495
SCHB Schwab U.S. Broad Market ETF 0.0000737379 22.971
SCHA Schwab U.S. Small-Cap ETF 0.000919644 26.4204
VXF Vanguard Extended Market Index Fund 0 195.75
IWC iShares Micro-Cap ETF 0.00512 129.106
VTSAX Vanguard Total Stock Market Index Fund 0 140.41
VIEIX Vanguard Extended Market Index Fund Institutional Shares 0 145.27
VITSX Vanguard Total Stock Market Index Fund 0 140.43
SWTSX Schwab Total Stock Market Index Fd Select Shs a Series of Schwab Capit 0.0000159221 98.66
VEXAX Vanguard Extended Market Index Fd Admiral Shs 0 145.28
VEMPX Vanguard Extended Market Index InstlPlus 0 358.5
VSMPX Vanguard Total Stock Mkt Idx Instl Pls 0 263.43
Unlock